134 related articles for article (PubMed ID: 12915045)
1. K+ channels and T-cell synapses: the molecular background for efficient immunomodulation is shaping up.
Matkó J
Trends Pharmacol Sci; 2003 Aug; 24(8):385-9. PubMed ID: 12915045
[TBL] [Abstract][Full Text] [Related]
2. Ion channels in T cells: from molecular pharmacology to therapy.
Krasznai Z
Arch Immunol Ther Exp (Warsz); 2005; 53(2):127-35. PubMed ID: 15928581
[TBL] [Abstract][Full Text] [Related]
3. Potassium channels as therapeutic targets for autoimmune disorders.
Wulff H; Beeton C; Chandy KG
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
[TBL] [Abstract][Full Text] [Related]
4. Ion channels and lymphocyte activation.
Panyi G; Varga Z; Gáspár R
Immunol Lett; 2004 Mar; 92(1-2):55-66. PubMed ID: 15081528
[TBL] [Abstract][Full Text] [Related]
5. Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins.
Levite M; Cahalon L; Peretz A; Hershkoviz R; Sobko A; Ariel A; Desai R; Attali B; Lider O
J Exp Med; 2000 Apr; 191(7):1167-76. PubMed ID: 10748234
[TBL] [Abstract][Full Text] [Related]
6. K+ channels as targets for specific immunomodulation.
Chandy KG; Wulff H; Beeton C; Pennington M; Gutman GA; Cahalan MD
Trends Pharmacol Sci; 2004 May; 25(5):280-9. PubMed ID: 15120495
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
[TBL] [Abstract][Full Text] [Related]
8. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.
Baell JB; Gable RW; Harvey AJ; Toovey N; Herzog T; Hänsel W; Wulff H
J Med Chem; 2004 Apr; 47(9):2326-36. PubMed ID: 15084131
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
Koo GC; Blake JT; Talento A; Nguyen M; Lin S; Sirotina A; Shah K; Mulvany K; Hora D; Cunningham P; Wunderler DL; McManus OB; Slaughter R; Bugianesi R; Felix J; Garcia M; Williamson J; Kaczorowski G; Sigal NH; Springer MS; Feeney W
J Immunol; 1997 Jun; 158(11):5120-8. PubMed ID: 9164927
[TBL] [Abstract][Full Text] [Related]
10. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
11. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
Koo GC; Blake JT; Shah K; Staruch MJ; Dumont F; Wunderler D; Sanchez M; McManus OB; Sirotina-Meisher A; Fischer P; Boltz RC; Goetz MA; Baker R; Bao J; Kayser F; Rupprecht KM; Parsons WH; Tong XC; Ita IE; Pivnichny J; Vincent S; Cunningham P; Hora D; Feeney W; Kaczorowski G
Cell Immunol; 1999 Nov; 197(2):99-107. PubMed ID: 10607427
[TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
13. Charybdotoxin-sensitive, Ca(2+)-dependent membrane potential changes are not involved in human T or B cell activation and proliferation.
Gelfand EW; Or R
J Immunol; 1991 Nov; 147(10):3452-8. PubMed ID: 1719077
[TBL] [Abstract][Full Text] [Related]
14. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
[TBL] [Abstract][Full Text] [Related]
15. The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.
Jensen BS; Hertz M; Christophersen P; Madsen LS
Expert Opin Ther Targets; 2002 Dec; 6(6):623-36. PubMed ID: 12472376
[TBL] [Abstract][Full Text] [Related]
16. Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca(2+)-activated over voltage-gated K(+) channels.
Rauer H; Lanigan MD; Pennington MW; Aiyar J; Ghanshani S; Cahalan MD; Norton RS; Chandy KG
J Biol Chem; 2000 Jan; 275(2):1201-8. PubMed ID: 10625664
[TBL] [Abstract][Full Text] [Related]
17. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
18. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
[TBL] [Abstract][Full Text] [Related]
19. Accessory Kvbeta1 subunits differentially modulate the functional expression of voltage-gated K+ channels in mouse ventricular myocytes.
Aimond F; Kwak SP; Rhodes KJ; Nerbonne JM
Circ Res; 2005 Mar; 96(4):451-8. PubMed ID: 15662035
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of voltage- and calcium-activated potassium channels in human B lymphocytes.
Partiseti M; Choquet D; Diu A; Korn H
J Immunol; 1992 Jun; 148(11):3361-8. PubMed ID: 1588037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
